Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688566'
s EV-to-FCF Range Over the Past 10 Years
Min: -567.76 Med: 35.15 Max: 979.22
Current: 58.55
During the past 10 years, the highest EV-to-FCF of Jiangsu Jibeier Pharmaceutical Co was 979.22. The lowest was -567.76. And the median was 35.15.
SHSE:688566's EV-to-FCF is ranked worse than 76.8% of 569
companies
in the Drug Manufacturers industry
Industry Median: 21.07
vs SHSE:688566: 58.55
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jiangsu Jibeier Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:
Jiangsu Jibeier Pharmaceutical Co's share price for today is ¥24.06.
Jiangsu Jibeier Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.270.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Jiangsu Jibeier Pharmaceutical Co EV-to-FCF Related Terms
Jiangsu Jibeier Pharmaceutical Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Jibeier Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Jibeier Pharmaceutical Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Jibeier Pharmaceutical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Jiangsu Jibeier Pharmaceutical Co's EV-to-FCF falls into.
Jiangsu Jibeier Pharmaceutical Co's current Enterprise Value is ¥4,156.9 Mil.
Jiangsu Jibeier Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥71.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) has a EV-to-FCF of 58.55 as of Jul. 23, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Jiangsu Jibeier Pharmaceutical Co and its competitors. This is 67% above median its historical median of 35.15. According to the industry distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #437 out of 569 companies in the Drug Manufacturers industry, placing it in the top 76.8%.
Is Jiangsu Jibeier Pharmaceutical Co's EV-to-FCF too high?
Jiangsu Jibeier Pharmaceutical Co's current EV-to-FCF of 58.55 is 67% above median its 10-year median of 35.15. The Drug Manufacturers industry median EV-to-FCF is 21.07. Jiangsu Jibeier Pharmaceutical Co's value of 58.55 is 177.9% above this industry median. Based on the distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #437 out of 569 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Jiangsu Jibeier Pharmaceutical Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Jibeier Pharmaceutical Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #437 out of 569 companies for EV-to-FCF. This places Jiangsu Jibeier Pharmaceutical Co in the lower half of its industry. The industry median EV-to-FCF is 21.07. Jiangsu Jibeier Pharmaceutical Co's value of 58.55 is 177.9% above this benchmark. While the company's 10-year median is 35.15 vs. the industry median of 21.07, Jiangsu Jibeier Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.07, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Jibeier Pharmaceutical Co's current EV-to-FCF of 58.55 is 177.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Jiangsu Jibeier Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Jibeier Pharmaceutical Co's current EV-to-FCF is 58.55, which is 67% above median its own 10-year median of 35.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Jibeier Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥35.31, compared to a current price of ¥24.06 — trading 31.9% below its estimated fair value. The current EV-to-FCF is 58.55, which is 67% above median its 10-year median of 35.15 and 177.9% above the Drug Manufacturers industry median of 21.07. Jiangsu Jibeier Pharmaceutical Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Jiangsu Jibeier Pharmaceutical Co (SHSE:688566), the current EV-to-FCF is 58.55 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Jibeier Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥24.06 is trading 31.9% below its estimated GF Value™ of ¥35.31.
GuruFocus considers Jiangsu Jibeier Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:688566:
EV-to-FCF: 58.55 (67% above median its 10-year median of 35.15)
GF Value™: ¥35.31 vs. price of ¥24.06 (31.9% below fair value)
Industry Position: 177.9% above the Drug Manufacturers median (#437 of 569)
No single metric tells the full story. See the SHSE:688566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Jibeier Pharmaceutical Co Business Description
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
85GF Score
Get the complete analysis for SHSE:688566
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688566 has been successfully added to your 
